Beth Totin is chief commercial officer, ApiJect Systems, Corp.

Beth Totin

Reducing Packaging Costs for Prefilled Syringes

Blow-fill-seal (BFS) technology presents an economical option for single-unit dose delivery of vaccines. Currently used for over-the-counter products, prescription medicines, and more than 50 injectable products, the authors present the case for using BFS for prefilled syringes. Factors including drug formulation, material compatibility, extractables and leachables, sterilization, and regulatory approval must be considered.

Pharmaceutical Technology's Biologics and Sterile Drug Manufacturing

Beth Totin is chief commercial officer, and Marcus Webb is director of communications, both with ApiJect Systems, Corp.

When referring to this article, please cite it as B. Totin and M. Webb, “Reducing Packaging Costs for Prefilled Syringes," 

Pharmaceutical Technology Biologics and Sterile Drug Manufacturing eBook

Articles

Blow-fill-seal (BFS) technology presents an economical option for single-unit dose delivery of vaccines. 